| Zhao Tong,Yuan Ling.Research progress of nuclear medicine imaging in the diagnosis of lymphoma drug-associated early lung injury[J].Chinese Journal of Radiological Medicine and Protection,2023,43(11):939-943 |
| Research progress of nuclear medicine imaging in the diagnosis of lymphoma drug-associated early lung injury |
| Received:May 19, 2023 |
| DOI：10.3760/cma.j.cn112271-20230519-00153 |
| KeyWords:Lymphoma Lung injury Positron-emission tomography |
| FundProject:山西省"四个一批"引导性科技专项基金(2021XM49) |
| Author Name | Affiliation | E-mail | | Zhao Tong | Department of Nuclear Medicine(PET/CT), Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China
School of Forensic Medicine, Shanxi Medical University, Taiyuan 030013, China | | | Yuan Ling | Department of Nuclear Medicine(PET/CT), Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China | yuanlinghjh01@sina.com |
|
| Hits: 2149 |
| Download times: 1032 |
| Abstract:: |
| Drug-associated lung injury (DALI) is one of the important factors affecting the prognosis of patients with lymphoma, and early identification and timely intervention for DALI are essential. Currently, the commonly used imaging examinations, e.g. high-resolution computed tomography, and laboratory tests all have hysteresis, so that the lung injury may be irreversible. Nuclear medicine imaging provides functional and metabolic information for DALI before morphological changes, so that the opportunity for early clinical intervention can be obtained. This article reviews the application of nuclear medicine imaging in lymphoma DALI. |
| HTML View Full Text View/Add Comment Download reader |
| Close |
|
|
|
